肝胆相照论坛

标题: CXCL13介导的肝内CXCR5 + CD8 + T细胞募集有助于慢性HBV感染的病 [打印本页]

作者: StephenW    时间: 2020-2-15 21:46     标题: CXCL13介导的肝内CXCR5 + CD8 + T细胞募集有助于慢性HBV感染的病

CXCL13-mediated recruitment of intrahepatic CXCR5+CD8+ T cells favors viral control in chronic HBV infection
Yongyin Li1,†
, Libo Tang1,†
, Ling Guo1,†
, Chengcong Chen1,†
, Shuqin Gu1
, Yang Zhou1
, Guofu Ye1
, Xiaoyi Li1
, Weibin Wang1
, Xinxin Liao2
, Yu Wang3
, Xiaohong Peng4
, Guangze Liu5
, Xiaoyong Zhang1
, Jian Sun1
, Jie Peng1
, Jinlin Hou1,low asterisk,'Correspondence information about the author Jinlin Hou
Highlights

    •

    CXCR5+CD8+T cells produce higher levels of HBV-specific IFN-γ and IL-21 than CXCR5−CD8+T cells.
    •

    CXCR5+CD8+T cells retain functional capacity in inhibiting HBV replication and supporting B cell antibody production.
    •

    PD1 blockade and exogenous IL-21 enhance production of IFN-γ from CXCR5+CD8+T cells.
    •

    High expression of intrahepatic CXCL13 facilitates CXCR5+CD8+T cell recruitment and promotes immune control of HBV.

Background & Aims

Although CD8+T cell exhaustion hampers viral control during chronic HBV infection, the pool of CD8+T cells is phenotypically and functionally heterogeneous. Therefore, a specific subpopulation of CD8+T cells should be further investigated. This study aims to dissect a subset of CD8+T cells expressing C-X-C motif chemokine receptor 5 (CXCR5) in chronic HBV infection.
Methods

The frequency of CXCR5+CD8+T cells and the levels of C-X-C motif chemokine ligand 13 (CXCL13), a chemokine of CXCR5, were measured in patients with chronic HBV infection. C57BL/6, interleukin (IL)-21 receptor- or B cell-deficient mice were hydrodynamically injected with pAAV-HBV1.2 plasmids. Phenotype and functions of peripheral and intrahepatic CXCR5+ and CXCR5−CD8+T cells were assessed.
Results

CXCR5+CD8+T cells were partially exhausted but possessed a stronger antiviral ability than the CXCR5− subset in patients with chronic HBV infection; moreover, CXCR5+CD8+T cells were associated with a favorable treatment response in patients with chronic hepatitis B (CHB). High levels of CXCL13 from patients with CHB facilitated the recruitment of intrahepatic CXCR5+CD8+T cells, and this subpopulation produced high levels of HBV-specific interferon (IFN)-γ and IL-21. Notably, PD1 (programmed death 1) blockade and exogenous IL-21 enhanced the production of IFN-γ. More strikingly, mice injected with CXCR5+CD8+T cells showed remarkably decreased expression of HBsAg. Additionally, an impaired production of HBV-specific IFN-γ from intrahepatic CXCR5+CD8+T cells was observed in IL-21 receptor- or B cell-deficient mice.
Conclusion

CXCL13 promotes the recruitment of CXCR5+CD8+T cells to the liver, and this subpopulation improves viral control in chronic HBV infection. The identification of this unique subpopulation may contribute to a better understanding of CD8+T cell functions and provide a potential immunotherapeutic target in chronic HBV infection.
Lay summary

Exhaustion of CD8+ T cells is an important factor in the development of chronic hepatitis B virus (HBV) infection. CD8+ T cells expressing the receptor CXCR5 are partially exhausted, but have potent antiviral activity, as they produce high levels of HBV-specific cytokines in chronic HBV infection. Increased expression of CXCL13 within the liver facilitates the recruitment of CXCR5+CD8+T cells and establishes effective immune control of HBV infection.
作者: StephenW    时间: 2020-2-15 21:47

CXCL13介导的肝内CXCR5 + CD8 + T细胞募集有助于慢性HBV感染的病毒控制
李永银1,†
,荔波堂1,†
,凌国1,†
陈成聪1,†
古树琴1
杨扬1
叶国富1
李晓怡1
王卫斌1
廖新新2
,于望3
彭晓红4
刘光泽5
张小勇1
孙健1
杰鹏1
,侯锦麟1,低星号,关于作者侯锦麟的通讯信息
强调



与CXCR5-CD8 + T细胞相比,CXCR5 + CD8 + T细胞产生更高水平的HBV特异性IFN-γ和IL-21。


CXCR5 + CD8 + T细胞保留了抑制HBV复制和支持B细胞抗体产生的功能。


PD1阻断和外源性IL-21增强了CXCR5 + CD8 + T细胞产生的IFN-γ。


肝内CXCL13的高表达促进CXCR5 + CD8 + T细胞募集并促进对HBV的免疫控制。

背景与目标

尽管CD8 + T细胞的衰竭阻碍了慢性HBV感染期间的病毒控制,但CD8 + T细胞库在表型和功能上是异质的。因此,应进一步研究CD8 + T细胞的特定亚群。这项研究旨在剖析在慢性HBV感染中表达CXC基序趋化因子受体5(CXCR5)的CD8 + T细胞的子集。
方法

在慢性HBV感染患者中,测量了CXCR5 + CD8 + T细胞的频率和CXCR5趋化因子CXC基序趋化因子配体13(CXCL13)的水平。向C57BL / 6,白细胞介素(IL)-21受体或B细胞缺陷小鼠灌输pAAV-HBV1.2质粒。评估外周和肝内CXCR5 +和CXCR5-CD8 + T细胞的表型和功能。
结果

在慢性HBV感染患者中,CXCR5 + CD8 + T细胞部分耗尽,但具有比CXCR5-亚组更强的抗病毒能力。此外,CXCR5 + CD8 + T细胞与慢性乙型肝炎(CHB)患者的良好治疗反应相关。来自CHB患者的高水平CXCL13促进了肝内CXCR5 + CD8 + T细胞的募集,并且该亚群产生了高水平的HBV特异性干扰素(IFN)-γ和IL-21。值得注意的是,PD1(程序性死亡1)阻滞和外源性IL-21增强了IFN-γ的产生。更惊人的是,注射了CXCR5 + CD8 + T细胞的小鼠显示HBsAg表达明显降低。另外,在IL-21受体缺陷或B细胞缺陷的小鼠中观察到肝内CXCR5 + CD8 + T细胞产生的HBV特异性IFN-γ受损。
结论

CXCL13促进CXCR5 + CD8 + T细胞向肝脏的募集,并且该亚群改善了慢性HBV感染中的病毒控制。鉴定这种独特的亚群可能有助于更好地了解CD8 + T细胞功能,并为慢性HBV感染提供潜在的免疫治疗靶标。
放置摘要

CD8 + T细胞的耗尽是慢性乙型肝炎病毒(HBV)感染发展的重要因素。表达受体CXCR5的CD8 + T细胞已部分耗尽,但具有有效的抗病毒活性,因为它们在慢性HBV感染中会产生高水平的HBV特异性细胞因子。肝脏中CXCL13表达的增加促进了CXCR5 + CD8 + T细胞的募集并建立了对HBV感染的有效免疫控制。
作者: StephenW    时间: 2020-2-15 21:47

https://www.journal-of-hepatolog ... aven_jbs_etoc_email
作者: 齐欢畅    时间: 2020-2-16 13:48

结论

CXCL13促进CXCR5 + CD8 + T细胞向肝脏的募集,并且该亚群改善了慢性HBV感染中的病毒控制。鉴定这种独特的亚群可能有助于更好地了解CD8 + T细胞功能,并为慢性HBV感染提供潜在的免疫治疗靶标。
放置摘要

CD8 + T细胞的耗尽是慢性乙型肝炎病毒(HBV)感染发展的重要因素。表达受体CXCR5的CD8 + T细胞已部分耗尽,但具有有效的抗病毒活性,因为它们在慢性HBV感染中会产生高水平的HBV特异性细胞因子。肝脏中CXCL13表达的增加促进了CXCR5 + CD8 + T细胞的募集并建立了对HBV感染的有效免疫控制。




欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) Powered by Discuz! X1.5